Loading...
Uploaded by abottdustin on Nov 26, 2008
After booking at least 25.6% short gains on Las Vegas Sands (LVS) in the official TFN tracking portfolio, TFN’s J. Christoph Amberger turned bearish on this biopharma company.
News & Politics
Standard YouTube License
Load more suggestions
Link to this comment:
All Comments (0)